Comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions

Credit: Kampus Production from Pexels

A team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *